Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis

2019

Harvey RD, Rubinstein WS, Ison G, Khozin S, Chen L, Miller RS, Jun M, Stepanski E, Hyde B, Uldrick TS, Komatsoulis GA, Roberts J, Garrett-Mayer E, Schilsky RL, Schenkel C, Kim ES, Bruinooge SS